Actively Recruiting
A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors
Led by Guangzhou Virotech Pharmaceutical Co., Ltd. · Updated on 2025-07-18
12
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
Sponsors
G
Guangzhou Virotech Pharmaceutical Co., Ltd.
Lead Sponsor
T
Third Affiliated Hospital, Sun Yat-Sen University
Collaborating Sponsor
AI-Summary
What this Trial Is About
A Phase I Study of the Safety and Tolerability of VRT106 Administered Intravenously for Treatment of Patients With Locally Advanced or MetastaticSolid Tumors
CONDITIONS
Official Title
A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntarily agree to participate, understand the study, and can complete all procedures
- Male or female aged 18 to 75 years at the time of informed consent
- Histologically or cytologically confirmed intolerant or refractory to standard systemic treatment
- Have at least one measurable lesion
- ECOG performance status of 0 to 2 within 28 days prior to first dose
- Expected survival time of at least 12 weeks
- Sufficient organ function
- Female patients of childbearing potential with a negative pregnancy test within 7 days prior to first dose
- Agree to use effective birth control from informed consent to 90 days after last dose (for males and females of childbearing potential)
You will not qualify if you...
- Received any antitumor therapy within 4 weeks prior to first dose
- Previously treated with oncolytic virus or other gene therapy
- Received other investigational drugs or devices within 4 weeks prior to first dose
- Known allergy to any components of the investigational medicinal product
- Women who are breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510000
Actively Recruiting
Research Team
T
Third Affiliated Hospital, Sun Yat-sen University
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here